Table 3.
Physicians’ assessments of changes in patients’ health following treatment with RCI.
| Category | n (%) (N = 302) |
|---|---|
| Patient’s current statusa | |
| Improved | 288 (95) |
| Not improved | 14 (5) |
| Type of treatment responseb | |
| Overall symptoms | 219 (73) |
| Lung function | 116 (38) |
| Inflammation | 100 (33) |
| Corticosteroid use (reduction or discontinuation) | 98 (32) |
| Quality of life | 96 (32) |
| Fatigue | 88 (29) |
| Other organ functions | 39 (13) |
| Pulmonary fibrosis | 34 (11) |
| Size of granulomas (inflamed lumps) | 29 (10) |
| Reducing immunosuppressant use | 22 (7) |
| Number of granulomas (inflamed lumps) | 20 (7) |
RCI, repository corticotropin injection.
a
Physicians’ responses to the question, ‘What is the patient’s status as of the end of RCI therapy or the 6 months point in therapy for ongoing treatment patients?’
b
Physicians’ responses to the question, ‘Please select the outcomes below that have improved as a result of RCI treatment.’ Since respondents could select all options that applied, the sum exceeds 100%.